HC Wainwright initiated coverage on MoonLake Immunotherapeutics (NASDAQ:MLTX) with a Buy rating and a price target of $28, citing a potentially best-in-class…
DocuSign Inc (NASDAQ: DOCU) has an elevated risk profile given the CEO transition, execution challenges, high employee turnover and a deteriorating macro environment, according to Piper Sandler.
Morgan Stanley analyst Erik Woodring saw Apple Inc's (NASDAQ: AAPL) pivot to a subscription-like model, making way for a market cap of over $3 trillion.
The S&P 500 has experienced 110 reversals in the previous 135 sessions, representing 1% shifts from high or low to close. Recent sessions have seen an extraordinary increase in the volume of buyers who are eager to acquire visibility.
Netflix, Inc. (NASDAQ: NFLX) shares gained 7.1% on Wednesday after the company reported better-than-expected subscriber losses in the second quarter and detailed plans to launch a new, low-cost, ad-supported subscription tier.
Chardan Research initiated coverage on Avidity Biosciences Inc (NASDAQ:RNA) with a Buy rating and a price target of $29 and Dyne Therapeutics Inc (NASDAQ:DYN) with…